Blockchain Registration Transaction Record

OSPRI Launches as First Fully Integrated PCR Testing Platform with $30M Backing

OSPRI emerges from merger of biotech leaders with $30M Catalio funding, revolutionizing PCR testing with 50% cost reduction and faster results for infectious disease detection.

This merger and funding announcement represents a significant advancement in healthcare accessibility and diagnostic efficiency. PCR testing has long been considered the gold standard for infectious disease detection, but its high costs and operational complexity have limited widespread adoption, particularly in smaller healthcare settings and underserved communities. OSPRI's integrated approach directly addresses these barriers by making advanced molecular testing more affordable, faster, and accessible to a broader range of healthcare providers. This matters because improved access to rapid, accurate diagnostic testing can lead to earlier detection of infectious diseases, more targeted treatments, reduced antibiotic misuse, and better patient outcomes. During times of public health crises, such capabilities become even more critical for effective disease containment and management.